Isolation and partial characterization of an antiviral, RC-183, from the edible mushroom Rozites caperata

Antiviral Research

Volumn 43, Issue 2, 1999, Pages 67-78

  Piraino, Frank ^a   Brandt, Curtis R ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Antiviral; Herpes simplex virus; Protein; Rozites caperata

Indexed keywords

ANTIVIRUS AGENT; RC 183; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STABILITY; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MASS SPECTROMETRY; MOUSE; MUSHROOM; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

AGARICALES; ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DNA VIRUSES; FUNGAL PROTEINS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INHIBITORY CONCENTRATION 50; KERATITIS, HERPETIC; MICE; MICROBIAL SENSITIVITY TESTS; RNA VIRUSES; VIRUS REPLICATION;

EID: 0032834126     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00035-2     Document Type: Article

References (37)

1. Ahmad A., Davies J., Randall S., Skinner G.R.B. Antiviral properties of extract of Opuntia streptacantha. Antiviral Res. 30:1996;75-85.
2. Aoki M., Tan M., Fukushima A., Hieda T., Mikaml Y. Antiviral substances with septimic effects produced by basidiomycetes such as Fomes fomentarius. Biosci. Biotech. Biochem. 57:1993;178-282.
3. Balick M.J., Cox P.A. Plants, People, and Culture: The Science of Ethnobotany. 1996;W.H. Freeman, New York. Scientific American Library.
4. Balish M.J., Abrams M.E., Chandler J.W., Brandt C.R. Interferon-α and interferon-γ induced modulation of proteins in human corneal fibroblasts. J. Interferon Res. 13:1993;289-294.
5. Brandt C.R., Coakley L., Grau D.R. A murine model of herpes simplex virus-induced ocular disease for antiviral drug testing. J. Virol. Methods. 36:1992;209-222.
6. Brandt C.R., Spencer B., Imesch P., Garneau M., Déziel R. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a model of herpes simplex virus type 1 ocular disease. Antimicrob. Agents Chemother. 40:1996;1078-1084.
7. Busch H., Goldknopt I.L. Ubiquitin-protein conjugates. Mol. Cell. Biochem. 40:1981;173-187.
8. Cox M.J., Shopira R., Wilkinson K.D. Tryptic peptide mapping of ubiquitin and derivatives using reverse-phase high performance liquid chromatography. Anal. Biochem. 154:1986;345-352.
9. Dopheide T.A.A., Moore S., Stein W.H. The carboxyl-terminal sequence of porcine pepsin. J. Biol. Chem. 242:1967;1833-1837.
10. Edman P. Method for determination of the amino acid sequence in peptides. Acta Chem. Scand. 4:1950;283-293.
11. Endo Y., Tsurugi K., Lambert J.M. The site of action of six different ribosome-inactivating proteins from plants on eukacyotic ribosomes: the RNA N-glycosidase activity of the proteins. Biochem. Biophys. Res. Commun. 150:1988;1032-1036.
12. Fischer D.G., Tal M., Novick D., Bavak S., Rubinstein M. An antiviral soluble form of the LDL receptor induced by interferon. Science. 262:1993;250-253.
13. Fujihara T., Hayashi K. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch. Virol. 140:1995;1469-1472.
14. Goldstein D.J., Weller S.K. Factor(s) present in herpes simplex virus type 1 infected cells can compensate for the loss of the large subunit of the virus ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology. 166:1988;41-51.
15. Goldstein G., Scheid M., Hammerling U., Boyse B.A., Schlesinger D.H., Niall H.D. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc. Natl. Acad. Sci. USA. 72:1975;11-15.
16. Grau D.R., Visalli R.J., Brandt C.R. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence. Invest. Ophthalmol. Vis. Sci. 30:1989;2474-2480.
17. Haas A.L., Wilkinson K.D. The large scale purification of ubiquitin from human erythrocytes. Prep. Biochem. 15:1985;49-60.
18. Hartley M.R., Leguame G., Osborn R., Chen Z., Lord J.M. Single chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett. 290:1991;65-68.
19. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:1996;405-439.
20. Holland L.E., Buthod J.L., Korval C.D., Antonucci T.K. Characterization of oxyphenarsine as a potential antiviral agent for AIDS. AIDS Res. Hum. Retroviruses. 8:1992;1717-1722.
21. Irvin J.D., Uckun F.M. Pokeweed antiviral protein ribosome inactivation and therapeutic applications. Pharmacol. Ther. 55:1992;279-302.
22. Isaacs A., Lindeman J. Virus interference. 1. The interferon. Proc. R. Soc. Lond. (Biol.). 147:1957;258-267.
23. Ito M., Barron A.L. Inactivation of HSV by concanavalin A. J. Virol. 13:1974;1312-1318.
24. Ito M., Girin L., Barron A.L. Inactivation of HCMV by PHA. Arch. Virol. 57:1978;97-105.
25. Khelita R., Menezes J. Epstein-Barr virus lymphoid cell interactima. III. Effect of concanavalin A and saccharides on Epstein-Barr virus penetration. J. Virol. 42:1982;402-410.
26. Kibby G. Mushrooms and other fungi. Steedman D. American Nature Guides. 1992;121 Smithmark, New York.
27. Lee-Huang S., Huang P.L., Jung H.F., Li B.-Q., Huang P.L., Huang P., Huan H.I., Chen H.-C. TAP 29: an antihuman immunodeficiency virus protein from Trichosanthus kirilowii is non-toxic to intact cells. Proc. Natl. Acad. Sci. USA. 88:1991;6570-6574.
28. Lifson J., Coutre S., Huang E., Engleman E. Role of envelope glycoprotein carbohydrate in human immunodeficiency virus infectivity and virus induced cell fusion. J. Exp. Med. 164:1986;2101-2106.
29. Liuzzi M., Déziel R., Moss N., Beaulieu P., Bonneau A.-M., Bousquet C., Chatouleas J.G., Garneau M., Javamillo J., Krogsrud R.L., Lagace L., McCollum R.S., Nawoot S., Guindon Y. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity. Nature. 372:1994;695-698.
30. Sarkar S., Koga J., Whitley R.J., Chatterjee S. Antiviral effect of the extract of culture medium of Lentinas edodes mycelia on the replication of herpes simplex virus type 1. Antiviral Res. 20:1993;293-303.
31. Schlesinger D.H., Goldstein G., Niall H.D. The complete amino acid sequence of ubiquitin, an adenylocyclase stimulating peptide probably universal in living cells. Biochemistry. 14:1975;2214-2218.
32. Sorimachi K., Akir N., Yamazaki S., Toda S., Yasumura Y. Anti-viral activity of water-solubilized lignin derivatives in vitro. Agric. Biol. Chem. 54:1990;1337-1339.
33. Suzuki H., Kenji I., Osamu Y. Structural characterization of the immunoactive and antiviral water-solubilized lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM). Agric. Biol. Chem. 54:1990;479-487.
34. Tochikura T.S., Nakashima H., Ohashi Y., Yamamoto N. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med. Microbiol. Immunol. 177:1988;235-244.
35. Vilček J., Sen G.C. Interferons and other cytokines. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.C., Monath T.P. et al. Fields Virology. 3rd ed:1996;375-399 Raven, Philadelphia.
36. Visalli R.J., Brandt C.R. The HSV-1 UL45 18-kDa gene product is a true late protein and a component of the virion. Virus Res. 29:1993;167-178.
37. Wilkinson K.D., Audhya T.K. Stimulation of ATP-dependent proteolysis requires ubiquitin with the COOH-terminal sequence Arg-Gly-Gly. J. Biol. Chem. 256:1981;9235-9241.